North America Urinalysis Market (2024-2029)
The North America Urinalysis Market was valued at $1459.1 Million in 2024 and projected to reach to $2231.3 Million by 2029, representing a compound annual growth rate of 8.9%. North America's urinalysis market is positioned for sustained expansion through 2029, supported by increasing chronic disease prevalence and heightened focus on preventive healthcare.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Urinalysis Market Trends and Insights
- North America's advanced healthcare infrastructure, high diagnostic adoption rates, and strong reimbursement frameworks are driving market expansion.
- The region benefits from increasing prevalence of chronic diseases and a growing emphasis on preventive healthcare, positioning North America as a key growth market for urinalysis solutions. North America's urinalysis market is characterized by significant technological innovation and the integration of automated diagnostic systems.
- Between 2024 and 2029, North America is expected to maintain steady growth momentum, supported by rising healthcare expenditures and improved laboratory automation.
- The region's mature healthcare ecosystem and regulatory clarity further strengthen North America's competitive advantage in the global urinalysis market..
Key Market Statistics
- CAGR (2024-2029) 8.9% CAGR
- Market Size, 2024 ~USD 1459.1 Million
- Forecast, 2029 ~USD 2231.3 Million
- Geography North America
North America Urinalysis Market Overview
Market Valuation & Growth :
North America's urinalysis market is valued at $1,459.1 million in 2024, with a projected CAGR of 8.9% through 2029, reaching $2,231.3 million. This growth outpaces many global regions, driven by strong healthcare spending and diagnostic infrastructure.
Advanced Healthcare Infrastructure :
The region benefits from state-of-the-art laboratory facilities, widespread adoption of automated urinalysis systems, and integration with electronic health records. This technological advancement accelerates diagnostic accuracy and market expansion across North America.
Strong Reimbursement Frameworks :
Robust insurance coverage and favorable reimbursement policies from Medicare, Medicaid, and private insurers in the US and Canada support consistent market growth. These frameworks ensure accessibility and affordability of urinalysis testing across diverse patient populations.
Chronic Disease Prevalence :
Rising incidence of diabetes, hypertension, and kidney disease in North America drives demand for routine urinalysis screening. Preventive healthcare initiatives and aging demographics further amplify the need for diagnostic testing services.
North America Urinalysis Market Dynamics
- The region's mature healthcare system, coupled with continuous technological innovations in diagnostic equipment, creates favorable conditions for market penetration and revenue growth. Key growth drivers include rising geriatric populations, expanded screening programs, and integration of point-of-care testing solutions.
- Investment in laboratory automation and AI-powered diagnostic tools will further enhance market dynamics.
- Strategic partnerships between diagnostic companies and healthcare providers are expected to accelerate adoption rates across clinical settings in North America..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- North America urinalysis market valued at $1,459.1M in 2024, expanding to $2,231.3M by 2029 at 8.9% CAGR
- North America's advanced healthcare infrastructure and high diagnostic adoption drive sustained market growth
- Automation and technological innovation in North America laboratories accelerate urinalysis testing efficiency
- North America's strong reimbursement policies and preventive healthcare focus support market expansion through 2029
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
North America Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
Target Audience
- Diagnostic Equipment Manufacturers : Manufacturers need North America market intelligence to optimize product development, pricing strategies, and distribution channels. Understanding regional adoption rates and technological preferences is critical for competitive positioning.
- Clinical Laboratory Operators : Laboratory networks require market forecasts and growth projections to plan capacity expansion, equipment investments, and service offerings. Regional data helps identify emerging opportunities in preventive and chronic disease screening.
- Healthcare Investors & Private Equity : Investment firms evaluating opportunities in North American diagnostics need market sizing, growth trajectories, and competitive dynamics. This data supports due diligence and valuation assessments for acquisition and portfolio decisions.
- Hospital & Healthcare Systems : Healthcare administrators require market insights to justify capital expenditures on urinalysis infrastructure, negotiate supplier contracts, and align diagnostic services with regional demand trends and reimbursement policies.
- Market Research & Consulting Firms : Research organizations need granular North America data to support client advisory services, competitive benchmarking, and strategic planning. Regional market intelligence enhances credibility and depth of consulting deliverables.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 1438.1 Million |
| Canada | USD 211.7 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($1,459.1M in 2024) with country-level breakdowns for the US and Canada, enabling accurate budget allocation and investment planning specific to this high-value region.
- Competitive Landscape Analysis : Understand market dynamics, key players, and competitive positioning within North America's advanced healthcare ecosystem. Identify growth opportunities and market gaps tailored to regional regulatory and reimbursement environments.
- Growth Driver Identification : Gain insights into North America-specific factors driving 8.9% CAGR, including chronic disease prevalence, aging demographics, and technological adoption. Leverage this intelligence to develop targeted market entry and expansion strategies.
- Reimbursement & Regulatory Insights : Access detailed analysis of Medicare, Medicaid, and private insurance reimbursement frameworks in the US and Canada. Understand regulatory pathways and compliance requirements essential for market success in North America.
- Strategic Decision Support : Make informed decisions on product launches, partnerships, and market investments with comprehensive North America-focused data. Benchmark performance against regional trends and identify high-potential market segments.
Frequently asked questions
What is the current size of the North America urinalysis market?
The North America urinalysis market was valued at $1,459.1 million in 2024 and is projected to reach $2,231.3 million by 2029.
What is the expected growth rate for North America's urinalysis market?
North America's urinalysis market is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2029.
What factors are driving growth in the North America urinalysis market?
Key drivers include advanced healthcare infrastructure, high diagnostic adoption rates, increasing chronic disease prevalence, strong reimbursement frameworks, and growing emphasis on preventive healthcare in North America.
How is automation impacting the North America urinalysis market?
Automation and technological innovation in North America laboratories are improving testing efficiency, reducing turnaround times, and enhancing diagnostic accuracy, thereby supporting market growth.
What is the forecast market size for North America urinalysis by 2029?
The North America urinalysis market is forecasted to reach $2,231.3 million by 2029, representing significant expansion from the 2024 baseline.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- Canada Urinalysis Market
- US Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
